Learn the trade here. Make it on tradeMONSTER

Options Trading News

December 11, 2012  Tue 8:56 AM CT

PCYC: SEE CHART GET CHAIN FIND STRATEGIES
Pharmacyclics is rising today after test results on a key cancer drug, and one trader is betting against a collapse in the biopharmaceutical stock.

optionMONSTER's tracking systems detected the sale of 2,000 May 36 puts in one print for $1. Open interest in the strike was just 36 contracts at the start of the session, so this is a new position.

PCYC is up 2.89 percent to $60.50 this morning after popping at the open. The company today reported positive findings in its Phase II trial of its ibrutinib drug, a proposed oral treatment for a form of lymphoma.

The stock gapped down from above $61 at the beginning of November but has been climbing since then. It rose above its 50-day moving average yesterday and above its 100-day average today.

Today's put seller is betting that PCYC will hold above the $36 strike price through expiration in mid-May 2013. The trader faces the obligation to buy the shares if the stock is below that level, but at an effective price of $35 once the credit from the put sale is included. (See our Education section)
Share this article with your friends


Premium Services

Free Webinars

Education & Strategy

Why traders hedge with sector ETFs

Many people who are not familiar with options think that they increase risk, but their first and primary purpose is...

View more education articles »
optionMONSTER stockMONSTER tradeMONSTER